BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25661993)

  • 1. Poly r(C) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells.
    Chen Q; Cai ZK; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
    Cell Physiol Biochem; 2015; 35(3):1052-61. PubMed ID: 25661993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sorting and identification of cancer stem cells in human prostate cancer cell lines].
    Luo Y; Cui XH; Jiang YG; Zhao JH; Zhao L; Chen YT; Li MC; Lin YH
    Zhonghua Nan Ke Xue; 2012 Dec; 18(12):1062-8. PubMed ID: 23405783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
    Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
    Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RNA-Binding Protein PCBP1 Functions as a Tumor Suppressor in Prostate Cancer by Inhibiting Mitogen Activated Protein Kinase 1.
    Zhang Y; Meng L; Xiao L; Liu R; Li Z; Wang YL
    Cell Physiol Biochem; 2018; 48(4):1747-1754. PubMed ID: 30078000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HN1L promotes stem cell-like properties by regulating TGF-β signaling pathway through targeting FOXP2 in prostate cancer.
    Nong S; Wang Z; Wei Z; Ma L; Guan Y; Ni J
    Cell Biol Int; 2022 Jan; 46(1):83-95. PubMed ID: 34519127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of cancer stem cells in human prostate cancer cells.
    Lee EK; Cho H; Kim CW
    Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
    Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
    Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis.
    Hurt EM; Kawasaki BT; Klarmann GJ; Thomas SB; Farrar WL
    Br J Cancer; 2008 Feb; 98(4):756-65. PubMed ID: 18268494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoprotective effect of neuropeptides on cancer stem cells: vasoactive intestinal peptide-induced antiapoptotic signaling.
    Sastry KS; Chouchane AI; Wang E; Kulik G; Marincola FM; Chouchane L
    Cell Death Dis; 2017 Jun; 8(6):e2844. PubMed ID: 28569785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell division cycle 20 (CDC20) drives prostate cancer progression via stabilization of β-catenin in cancer stem-like cells.
    Zhang Q; Huang H; Liu A; Li J; Liu C; Sun B; Chen L; Gao Y; Xu D; Su C
    EBioMedicine; 2019 Apr; 42():397-407. PubMed ID: 30904606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
    Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
    J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
    Guo Y; Kyprianou N
    Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
    Rybak AP; He L; Kapoor A; Cutz JC; Tang D
    Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen receptor signaling pathway activated by phthalates is linked with transforming growth factor-β in the progression of LNCaP prostate cancer models.
    Lee HR; Hwang KA; Choi KC
    Int J Oncol; 2014 Aug; 45(2):595-602. PubMed ID: 24858230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
    Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
    Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enrichment of the Cancer Stem Phenotype in Sphere Cultures of Prostate Cancer Cell Lines Occurs through Activation of Developmental Pathways Mediated by the Transcriptional Regulator ΔNp63α.
    Portillo-Lara R; Alvarez MM
    PLoS One; 2015; 10(6):e0130118. PubMed ID: 26110651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.
    Li X; Grigalavicius M; Li Y; Li X; Zhong Y; Huang R; Yu D; Berge V; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
    Tumour Biol; 2017 Aug; 39(8):1010428317713671. PubMed ID: 28789597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.